485821-29-2

Basic information

• Product Name: 8-(3-aminoazepan-1-yl)-7-(2-bromobenzyl)-3-methyl-3,7-dihydropurine-2,6-dione trifluoroacetate
• Synonyms: 8-(3-aminoazepan-1-yl)-7-(2-bromobenzyl)-3-methyl-3,7-dihydropurine-2,6-dione trifluoroacetate
• CAS NO: 485821-29-2
• Molecular Weight: 561.359
• Mol File: 485821-29-2.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: 8-(3-aminoazepan-1-yl)-7-(2-bromobenzyl)-3-methyl-3,7-dihydropurine-2,6-dione trifluoroacetate(CAS DataBase Reference)
• NIST Chemistry Reference: 8-(3-aminoazepan-1-yl)-7-(2-bromobenzyl)-3-methyl-3,7-dihydropurine-2,6-dione trifluoroacetate(485821-29-2)
• EPA Substance Registry System: 8-(3-aminoazepan-1-yl)-7-(2-bromobenzyl)-3-methyl-3,7-dihydropurine-2,6-dione trifluoroacetate(485821-29-2)

Safety Data

• Hazardous Substances Data: 485821-29-2(Hazardous Substances Data)

Upstream product

• 485821-30-5 8-bromo-7-(2-bromobenzyl)-3-methyl-3,7-dihydropurine-2,6-dione 
• 69154-03-6 DL-3-aminohexahydro-1H-azepin 

Relevant articles and documents

SUCCINATE SALTS OF HETEROCYCLIC DPP-IV INHIBITORS

The present invention relates to therapeutically active and selective hemisuccinate salts of inhibitors of the enzyme DPP-IV of formula (I), pharmaceutical compositions comprising the salts and the use of such salts for and the manufacture of medicaments for treating diseases that are associated with proteins that are subject to inactivation by DPP-IV, such as type 2 diabetes and obesity.